Literature DB >> 16204787

New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.

F J van Overveld1, U Demkow, D Górecka, W A de Backer, J Zielinski.   

Abstract

Inhaled corticosteroids (ICS) are widely used for the treatment of COPD despite of controversial statements concerning their efficacy. The use of N-acetylcysteine (NAC), a mucolytic drug with antioxidant properties, is less clear, but it may counteract the oxidant-antioxidant imbalance in COPD. The aim of this study was to evaluate whether treatment of COPD patients with ICS or NAC is able to improve inflammatory indices and to enhance lung function. ICS treatment enhanced protective markers for oxidative stress such as glutathione peroxidase (GPx) (51.2 +/-5.8 vs. 62.2 +/-8.6 U/g Hb, P<0.02) and trolox-equivalent antioxidant capacity (TEAC) (1.44 +/-0.05 vs. 1.52 +/-0.06 mM, P<0.05). NAC decreased sputum eosinophil cationic protein (318 +/-73 vs. 163 +/-30 ng/ml, P<0.01) and sputum IL-8 (429 +/-80 vs. 347 +/-70 ng/ml, P<0.05). The increased antioxidant capacity prevented an up-regulation of adhesion molecules, since the levels of intracellular adhesion molecule 1 (ICAM-1) correlated negatively with GPx (P<0.0001) and TEAC (P<0.0001). On the other hand, expression of adhesion molecules was promoted by inflammation, reflected by a positive correlation between the levels of IL-8 and ICAM-1 (P<0.0001). The effects of treatment on lung function were only reflected in the FEV(1) values. The absolute value of FEV(1), both before and after salbutamol inhalation, increased from 1690 +/-98 to 1764 +/-110 ml, and 1818 +/-106 to 1906 +/-116 ml, respectively, after ICS (P<0.05) . Ten weeks after treatment, FEV(1) values dropped to 1716 +/-120 ml post-salbutamol (P<0.05). When followed by treatment with NAC, these values decreased even further to 1666 +/-84 ml. These results suggest that ICS improved lung function in COPD patients with moderate airflow obstruction, beside a minor improvement in the oxidant-antioxidant imbalance leading to a lesser expression of ICAM-1. Treatment with NAC decreased some inflammatory parameters and had indirectly an inhibitory effect on the expression of adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204787

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  11 in total

Review 1.  Antioxidant pharmacological therapies for COPD.

Authors:  Irfan Rahman; William MacNee
Journal:  Curr Opin Pharmacol       Date:  2012-02-18       Impact factor: 5.547

Review 2.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

Review 3.  Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-04       Impact factor: 4.219

Review 4.  Pathogenesis of inflammation and repair in advanced COPD.

Authors:  William D Cornwell; Victor Kim; Changcheng Song; Thomas J Rogers
Journal:  Semin Respir Crit Care Med       Date:  2010-05-21       Impact factor: 3.119

Review 5.  Targeted antioxidants as therapeutics for treatment of pneumonia in the elderly.

Authors:  Stefi F Lee; Rebecca Harris; Heather W Stout-Delgado
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

Review 6.  Antioxidant therapeutic advances in COPD.

Authors:  Irfan Rahman
Journal:  Ther Adv Respir Dis       Date:  2008-12       Impact factor: 4.031

7.  Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.

Authors:  Jian-Qing Zhang; Jia-Qiang Zhang; Hua Liu; Zhi-Huan Zhao; Li-Zhou Fang; Ling Liu; Wei-Ping Fu; Jing-Kui Shu; Jia-Gang Feng; Lu-Ming Dai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-13

8.  Examination of the Ability of N-acetylcysteine Administration during Anesthesia to Prevent Perioperative Deterioration of Pulmonary Function in Patients Undergoing Nephrectomy.

Authors:  Dea Ja Um; Seok-Joo Hong; Jong Taek Park
Journal:  J Lifestyle Med       Date:  2014-09-30

Review 9.  Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment.

Authors:  Urszula Demkow; F J van Overveld
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

Review 10.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.